Searchable abstracts of presentations at key conferences in endocrinology

ea0028p53 | Clinical practice/governance and case reports | SFEBES2012

Antiphospholipid syndrome and adrenal insufficiency: a case series

Whyte Martin , Grove Grace , McGowan Barbara , Carroll Paul , Powrie Jake

Introduction: Antiphospholipid syndrome (APS) is the association of anti-cardiolipin antibodies and venous & arterial thrombosis. APS accounts for <0.5% of cases of hypoadrenalism. We present a series of 5 such cases occurring at our institution plus a further patient identified with unilateral adrenal haemorrhage. Case 1 presented with nausea, vomiting and weight loss. Lupus anticoagulant positive. Commenced aspirin 300 mg. 6-weeks later represented with dehydration, ...

ea0025p130 | Diabetes, metabolism and cardiovascular | SFEBES2011

Cabergoline prevents weight gain in patients evaluated for hyperprolactinaemia

Whyte Martin , Aziz Riaz , Pramodh Sesha , Aylwin Simon

Introduction: Food reward stimuli elevate dopamine levels in brain reward circuits. Decreased dopaminergic signalling may be involved in pathophysiological processes leading to obesity and D2 receptor antagonists (antipsychotics) are associated with a higher risk of obesity. One study has demonstrated an association between the use of a dopamine D2 agonist (bromocriptine) and weight-loss in patients with prolactinoma. We have investigated the effect of cabergoline on body weig...

ea0021p87 | Clinical practice/governance and case reports | SFEBES2009

An unusual case of vitamin D deficiency and Wernicke-Korsakoff syndrome

Cheah Yee Seun , Whyte Martin , Aylwin Simon , Gilbert Jackie

A 30-year-old Eritrean female presented with a 1 month history of nausea and vomiting, with 15 kg weight loss but no bowel disturbance. Past medical history included an open cholecystectomy. There was no family history of mineral or bone disorders. She denied any prescribed/over-counter medication and abstained from alcohol. Examination revealed marked cachexia (BMI 16.1 kg/m2). ECG revealed ST depression and T wave inversion.Investigations in...

ea0021p289 | Pituitary | SFEBES2009

A fall in serum prolactin level after a 2-h rest predicts a normal MRI in patients using dopamine antagonist treatment

Whyte Martin , Allum Matthew , Pramodh Sesha , Aylwin Simon

Introduction: Hyperprolactinaemia associated with antipsychotic drug use is a commonly encountered clinical problem, yet no decision-making tools exist to guide whether to scan the pituitary gland.Methods: A 10-year data series was reviewed of 246 patients who were evaluated for prolactin excess with a cannulated prolactin study. All patients had a prolactin drawn immediately following the insertion of a forearm cannula (P1) and a second sampl...

ea0015p97 | Clinical practice/governance and case reports | SFEBES2008

Onset of severe hyponatraemia during hospitalisation carries a worse prognosis than severe hyponatraemia present on admission

Whyte Martin , Down Colin , Miell John , Crook Martin

The risk of death with severe hyponatraemia is well known. What is less clear is the mortality risk according to the pattern of the developing hyponatraemia.Methods: From our laboratory database we retrospectively collected data of all adult patients with severe hyponatraemia (<120 mmol/l) over 6 months. Of 49 155 samples, 101 (0.2%) were <120 mmol/l, obtained from n=54 patients. Two paediatric cases were excluded leaving n=52. Norm...

ea0077p6 | Adrenal and Cardiovascular | SFEBES2021

The effect of plasma potassium on hospital length of stay in unselected acute admissions

Ellis Hugh Logan , Sharpe Claire , Kelly Philip , Al-Agil Mohammad , Teo James , Whyte Martin

Introduction: Hypo-&hyperkalaemia are common laboratory abnormalities, complicating up to 10% of all hospital admissions and contributing to mortality. Ideally, patients with mild deviations can be treated as outpatients, and only those patients with objectively severe or life-threatening levels are hospitalized. Once admitted, there are few data as to whether the degree of electrolyte disturbance consumes greater resource(s). We analysed the admission and discharge data, ...

ea0077p90 | Neuroendocrinology and Pituitary | SFEBES2021

Hypo and hypernatraemia on admission are associated with increased length of stay in unselected acute hospital admissions

Ellis Hugh Logan , Sharpe Claire , Kelly Phil , Al-Agil Mohammad , Teo James , Aylwin Simon , Whyte Martin

Introduction: Hyponatraemia is a common biochemical abnormality, complicating up to 15% of all hospital admissions and associated with increased mortality. Hypernatraemia, occuring less frequently, is strongly associated with mortality and is almost always due to a free water deficit. There is limited data about hospital healthcare burden of these two relatively common electrolyte imbalances. We analysed the length of stay, for acute admissions, with reference to the admission...

ea0094p230 | Metabolism, Obesity and Diabetes | SFEBES2023

Case report - success story of GLP-1 agonist (liraglutide) treatment in someone with type 1 diabetes: A life transformed

Heald Adrian , Whyte Martin , Warner-Levy John , Belston Lleyton , Horne LInda , Gibson Martin

Introduction: Glucagon-like peptide-1(GLP-1) agonists are widely used for treatment of type 2 diabetes(T2D). To date a number of reports have described improvements in glucose control with the addition of a GLP-1 agonist to the insulin regime in treatment of type 1 diabetes(T1D). From a physiological perspective there is credence to the notion that a GLP-1 agonist will lower glucose levels in people with T1D as they do in T2D. GLP-1 is an endogenous hormone th...

ea0013oc20 | Novartis Basic Endocrinology Award | SFEBES2007

Insulin fails to limit proteolysis in critically-ill medical patients to rates observed after cardiothoracic surgery

Whyte Martin , Jackson Nicola , Shojaee-Moradie Fariba , Beale Richard , Treacher David , Blauth Christopher , Jones Richard , Umpleby Margot

Recent data suggest that critically-ill medical patients might not obtain as much benefit from insulin therapy as cardiothoracic patients. This may be because medical patients are more insulin resistant. We have investigated this in both groups.10 medical patients (age 67.0±4.4 y; 7M:3F, BMI 24.0±1.7 kg/m2; studied within 36 hours of admission to the ICU) and 7 post-operative cardiothoracic patients (age 71.4±3.8 y; 5M:2F, BMI 2...